Allosteric Hotspots in the Main Protease of SARS-CoV-2

被引:9
|
作者
Stromich, Leonie [1 ]
Wu, Nan [1 ]
Barahona, Mauricio [2 ]
Yaliraki, Sophia N. [1 ]
机构
[1] Imperial Coll London, Dept Chem, London, England
[2] Imperial Coll London, Dept Math, London, England
基金
英国工程与自然科学研究理事会; 英国惠康基金;
关键词
graph theory; allosteric site prediction; atomistic graph representation; SARS-CoV-2; 3C-LIKE PROTEASE; SARS; DESIGN; SITES; PREDICTION; REVEALS; COMPLEX; IDENTIFICATION; PROTEINS; TARGET;
D O I
10.1016/j.jmb.2022.167748
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibiting the main protease of SARS-CoV-2 is of great interest in tackling the COVID-19 pandemic caused by the virus. Most efforts have been centred on inhibiting the binding site of the enzyme. However, considering allosteric sites, distant from the active or orthosteric site, broadens the search space for drug candidates and confers the advantages of allosteric drug targeting. Here, we report the allosteric commu-nication pathways in the main protease dimer by using two novel fully atomistic graph-theoretical meth-ods: Bond-to-bond propensity, which has been previously successful in identifying allosteric sites in extensive benchmark data sets without a priori knowledge, and Markov transient analysis, which has pre-viously aided in finding novel drug targets in catalytic protein families. Using statistical bootstrapping, we score the highest ranking sites against random sites at similar distances, and we identify four statistically significant putative allosteric sites as good candidates for alternative drug targeting.(c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecom-mons.org/licenses/by/4.0/).
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Allosteric Modulation of the Main Protease (MPro) of SARS-CoV-2 by Casticin—Insights from Molecular Dynamics Simulations
    Jehoshaphat Oppong Mensah
    Gilbert Boadu Ampomah
    Edward Ntim Gasu
    Abigail Kusiwaa Adomako
    Elliott Sarpong Menkah
    Lawrence Sheringham Borquaye
    Chemistry Africa, 2022, 5 : 1305 - 1320
  • [42] X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
    Guenther, Sebastian
    Reinke, Patrick Y. A.
    Fernandez-Garcia, Yaiza
    Lieske, Julia
    Lane, Thomas J.
    Ginn, Helen M.
    Koua, Faisal H. M.
    Ehrt, Christiane
    Ewert, Wiebke
    Oberthuer, Dominik
    Yefanov, Oleksandr
    Meier, Susanne
    Lorenzen, Kristina
    Krichel, Boris
    Kopicki, Janine-Denise
    Gelisio, Luca
    Brehm, Wolfgang
    Dunkel, Ilona
    Seychell, Brandon
    Gieseler, Henry
    Norton-Baker, Brenna
    Escudero-Perez, Beatriz
    Domaracky, Martin
    Saouane, Sofiane
    Tolstikova, Alexandra
    White, Thomas A.
    Haenle, Anna
    Groessler, Michael
    Fleckenstein, Holger
    Trost, Fabian
    Galchenkova, Marina
    Gevorkov, Yaroslav
    Li, Chufeng
    Awel, Salah
    Peck, Ariana
    Barthelmess, Miriam
    Schluenzen, Frank
    Xavier, P. Lourdu
    Werner, Nadine
    Andaleeb, Hina
    Ullah, Najeeb
    Falke, Sven
    Srinivasan, Vasundara
    Franca, Bruno Alves
    Schwinzer, Martin
    Brognaro, Hevila
    Rogers, Cromarte
    Melo, Diogo
    Zaitseva-Doyle, Joanna J.
    Knoska, Juraj
    SCIENCE, 2021, 372 (6542) : 642 - +
  • [43] A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis
    Fatima, Asma
    Geethakumari, Anupriya M.
    Ahmed, Wesam S.
    Biswas, Kabir H.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [44] Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV-2 Mpro)
    Azevedo, Pedro Henrique R. de A.
    Camargo, Priscila G.
    Constant, Larissa E. C.
    Costa, Stephany da S.
    Silva, Celimar Sinezia
    Rosa, Alice S.
    Souza, Daniel D. C.
    Tucci, Amanda R.
    Ferreira, Vivian N. S.
    Oliveira, Thamara Kelcya F.
    Borba, Nathalia R. R.
    Rodrigues, Carlos R.
    Albuquerque, Magaly G.
    Dias, Luiza R. S.
    Garrett, Rafael
    Miranda, Milene D.
    Allonso, Diego
    Lima, Camilo Henrique da S.
    Muri, Estela Maris F.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2
    Thakur, Abhishek
    Sharma, Gaurav
    Badavath, Vishnu Nayak
    Jayaprakash, Venkatesan
    Merz, Kenneth M., Jr.
    Blum, Galia
    Acevedo, Orlando
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2022, 13 (25): : 5776 - 5786
  • [46] The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus
    Issa, Shaza S.
    Sokornova, Sofia, V
    Zhidkin, Roman R.
    Matveeva, Tatiana, V
    PLANTS-BASEL, 2022, 11 (14):
  • [47] Structural insights into SARS-CoV-2 main protease conformational plasticity
    Dehury, Budheswar
    Mishra, Sarbani
    Pati, Sanghamitra
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2023, 124 (06) : 861 - 876
  • [48] Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease
    Sarkar, Arighna
    Mandal, Kalyaneswar
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (44) : 23492 - 23494
  • [49] Investigating the Inhibition of Diindolylmethane Derivatives on SARS-CoV-2 Main Protease
    Li, Wenjin
    Chang, Xiaoyu
    Zhou, Hang
    Yu, Wenquan
    Wang, Ruiyong
    Chang, Junbiao
    JOURNAL OF MOLECULAR RECOGNITION, 2024,
  • [50] Structural insights into SARS-CoV-2 Main Protease maturation process
    Noske, Gabriela Dias
    Nakamura, Aline Minali
    Gawriljuk, Victor Oliveira
    Fernandes, Rafaela Sachetto
    Godoy, Andre Schutzer
    Oliva, Glaucius
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1372 - 1372